World's Best Scientists 2026 revealed!
Kazuo Mishima

Kazuo Mishima

D-Index & Metrics

Neuroscience

D-Index
48
Citations
9082
World Ranking
6179
National Ranking
199

Kazuo Mishima publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Kazuo Mishima sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 188 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Kazuo Mishima D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Kazuo Mishima sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 48 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Kazuo Mishima is affiliated with Akita University in Japan and has contributed extensively to research in medicine, psychology, and neuroscience. Their work spans over 105 publications in medicine, 76 in psychology, and 57 in neuroscience, reflecting a broad engagement with health and cognitive sciences.

Their research predominantly covers subfields such as experimental and cognitive psychology, cognitive neuroscience, and psychiatry and mental health. Other areas of specialization include education and endocrine and autonomic systems research. Mishima's main topics of interest include sleep and related disorders, sleep and wakefulness research, and youth substance use and school attendance. Additionally, they have contributed to studies on schizophrenia research and treatment, circadian rhythm and melatonin, electroconvulsive therapy studies, and sleep and work-related fatigue.

Frequent publication venues for Mishima's work include Neuropsychopharmacology Reports and Scientific Reports, each with eight publications. Other significant outlets are Frontiers in Psychiatry, BMC Psychiatry, and Psychiatry and Clinical Neurosciences. These venues underline a consistent presence in psychiatric and neuroscientific academic journals.

Mishima has collaborated regularly with several co-authors notable for multiple joint publications. These include Masahiro Takeshima, Ken Inada, Naoko Ayabe, Masaya Ogasawara, and Yu Itoh. These collaborations indicate ongoing research partnerships within their academic network.

The scientist has contributed to numerous papers, including:

  • Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials, 2020, Molecular Psychiatry
  • Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis, 2020, Molecular Psychiatry
  • Cross-sectional survey of depressive symptoms and suicide-related ideation at a Japanese national university during the COVID-19 stay-home order, 2021, Environmental Health and Preventive Medicine
  • Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020, 2022, Respiratory Investigation
  • Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders, 2020, BMC Psychiatry

Best Publications

  • Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome

    Takashi Ebisawa;Makoto Uchiyama;Naofumi Kajimura;Kazuo Mishima

  • Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia

    K. Mishima;M. Okawa;Y. Hishikawa;S. Hozumi

  • Diminished melatonin secretion in the elderly caused by insufficient environmental illumination.

    K. Mishima;M. Okawa;T. Shimizu;Y. Hishikawa

  • Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking

    Kazuo Mishima;Tozawa Tozawa;Kohtoku Satoh;Yasuhiro Matsumoto

  • EVENING PREFERENCE IS RELATED TO THE INCIDENCE OF DEPRESSIVE STATES INDEPENDENT OF SLEEP-WAKE CONDITIONS

    Shingo Kitamura;Akiko Hida;Makiko Watanabe;Minori Enomoto

  • The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample.

    Kazuo Mishima;Takuma Tozawa;Kohtoku Satoh;Hidetomo Saitoh

  • Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment.

    M Okawa;K Mishima;Y Hishikawa;S Hozumi

  • Sleep debt elicits negative emotional reaction through diminished amygdala-anterior cingulate functional connectivity.

    Yuki Motomura;Shingo Kitamura;Kentaro Oba;Yuri Terasawa

  • Human blood metabolite timetable indicates internal body time

    Takeya Kasukawa;Masahiro Sugimoto;Masahiro Sugimoto;Akiko Hida;Yoichi Minami

  • Mutation screening of the human Clock gene in circadian rhythm sleep disorders.

    Toshio Iwase;Naofumi Kajimura;Makoto Uchiyama;Takashi Ebisawa

  • Validity of the Japanese version of the Munich ChronoType Questionnaire

    Shingo Kitamura;Akiko Hida;Sayaka Aritake;Shigekazu Higuchi

  • Vitamin B12 Treatment for Sleep-Wake Rhythm Disorders

    M Okawa;K Mishima;T Nanami;T Shimizu

  • A missense variation in human Casein kinase I Epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders

    Atsuko Takano;Makoto Uchiyama;Naofumi Kajimura;Kazuo Mishima

  • Randomized, DIM Light Controlled, Crossover test of Morning Bright Light Therapy for Rest-Activity Rhythm Disorders in Patients with Vascular Dementia and Dementia of Alzheimer's type

    Kazuo Mishima;Yasuo Hishikawa;Masako Okawa

  • Differential Response of Period 1 Expression within the Suprachiasmatic Nucleus

    Wataru Nakamura;Shin Yamazaki;Shin Yamazaki;Nana N. Takasu;Nana N. Takasu;Kazuo Mishima;Kazuo Mishima

  • Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.

    Taro Kishi;Toshikazu Ikuta;Yuki Matsuda;Kenji Sakuma

  • Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons.

    K. Mishima;M. Okawa;S. Hozumi;Y. Hishikawa

  • Molecular and immunological characterization of ADP-ribosylarginine hydrolases.

    J. Moss;S. J. Stanley;M. S. Nightingale;J. J. Murtagh

  • Screening of Clock Gene Polymorphisms Demonstrates Association of a PER3 Polymorphism with Morningness–Eveningness Preference and Circadian Rhythm Sleep Disorder

    Akiko Hida;Shingo Kitamura;Yasuko Katayose;Mie Kato

  • Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.

    J. J. Murtagh;M. R. Mowatt;Chii-Ming Lee;Fang-Jen Scott Lee

  • Two pedigrees of familial advanced sleep phase syndrome in Japan.

    Kohtoku Satoh;Kazuo Mishima;Yuichi Inoue;Takashi Ebisawa

  • Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.

    Taro Kishi;Kenji Sakuma;Ikuo Nomura;Yuki Matsuda

Frequent Co-Authors

Takashi Kanbayashi
Takashi Kanbayashi University of Tsukuba
Masako Okawa
Masako Okawa Shiga University of Medical Science
Nakao Iwata
Nakao Iwata Fujita Health University
Kazuhiko Kume
Kazuhiko Kume Nagoya City University
Katsushi Tokunaga
Katsushi Tokunaga University of Tokyo
Kiyohisa Takahashi
Kiyohisa Takahashi Shiga University of Medical Science
Yoshiharu Kim
Yoshiharu Kim National Center of Neurology and Psychiatry
Mitsuhiro Kato
Mitsuhiro Kato Showa University
Shin Yamazaki
Shin Yamazaki The University of Texas Southwestern Medical Center
Takashi Shimizu
Takashi Shimizu Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Kazuo Mishima

Trending Scientists

Recently Published Articles